Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial

Katharine A. Phillips, Aparna Keshaviah, Darin D. Dougherty, Robert L. Stout, William Menard and Sabine Wilhelm

Mathematica Policy Research Reports from Mathematica Policy Research

Abstract: Continuation-phase escitalopram delayed time to relapse, and fewer escitalopram-treated subjects relapsed than did placebo-treated subjects.

Keywords: Pharmacotherapy; body dysmophic disorder (search for similar items in EconPapers)
New Economics Papers: this item is included in nep-exp, nep-hea and nep-pr~
References: Add references at CitEc
Citations:

Downloads: (external link)
http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2016.15091243 (text/html)
Our link check indicates that this URL is bad, the error code is: 403 Forbidden (http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2016.15091243 [301 Moved Permanently]--> https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2016.15091243 [301 Moved Permanently]--> https://psychiatryonline.org/doi/10.1176/appi.ajp.2016.15091243)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mpr:mprres:16d61a5c8641445e891d6509903cf174

Access Statistics for this paper

More papers in Mathematica Policy Research Reports from Mathematica Policy Research Mathematica Policy Research P.O. Box 2393 Princeton, NJ 08543-2393 Attn: Communications. Contact information at EDIRC.
Bibliographic data for series maintained by Joanne Pfleiderer () and Cindy George ( this e-mail address is bad, please contact ).